The U.S. Food and Drug Administration today approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia. “This new drug provides another option for the treatment of patients...

Heart complications in patients diagnosed with bacterial pneumonia are more serious than in patients diagnosed with viral pneumonia, according to new research from the Intermountain Heart Institute at...

When U.S. adults are hospitalized with pneumonia, viruses are more often to blame than bacteria.  However, despite current diagnostic tests, neither viruses nor bacteria are detected in the majority of...